Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Heron Begins Phase 2 Clinical Study of Cinvanti for COVID-19

americanpharmaceuticalreviewJuly 27, 2020

Tag: Heron , Cinvanti , COVID-19 , Aprepitant

PharmaSources Customer Service